Jacopo C DiFrancesco Selected Research

Jacopo C DiFrancesco Research Topics

Disease

15	Epilepsy (Aura) 12/2023 - 07/2010
7	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 09/2023 - 04/2013
6	Alzheimer Disease (Alzheimer's Disease) 09/2022 - 04/2013
6	Inflammation (Inflammations) 09/2022 - 04/2013
5	Brain Diseases (Brain Disorder) 12/2023 - 10/2018
3	Seizures (Absence Seizure) 01/2024 - 10/2018
2	Edema (Dropsy) 09/2022 - 04/2013
2	Dementia (Dementias) 10/2019 - 01/2015
2	Nervous System Diseases (Neurological Disorders) 06/2019 - 11/2018
1	Partial Epilepsies (Epilepsy, Partial) 01/2024
1	Generalized Epilepsy 12/2023
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 09/2023
1	Brain Neoplasms (Brain Tumor) 02/2023
1	Neoplasms (Cancer) 02/2023
1	Cognitive Dysfunction 01/2020
1	Amyloidosis 01/2020
1	Glut1 Deficiency Syndrome 06/2019
1	Infantile Epileptic-Dyskinetic Encephalopathy 10/2018
1	Siderosis 01/2018
1	Neurologic Manifestations (Neurological Manifestations) 01/2018
1	Epilepsia Partialis Continua 04/2017
1	Alternating hemiplegia of childhood 04/2017
1	Stroke (Strokes) 02/2015
1	Paresis (Hemiparesis) 01/2015
1	Pain (Aches) 01/2015
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2015
1	Thrombosis (Thrombus) 01/2015
1	Vasculitis (Vasculitides) 01/2015
1	Delirium 01/2015
1	Guillain-Barre Syndrome 01/2015
1	Neurofibromatosis 2 (Neurofibromatosis Type II) 03/2014
1	Multiple Sclerosis 04/2013
1	Idiopathic Generalized Epilepsy 11/2011
1	Channelopathies 07/2010
1	MELAS Syndrome (Syndrome, MELAS) 07/2008
1	Osteosarcoma (Osteogenic Sarcoma) 07/2008

Drug/Important Bio-Agent (IBA)

7	Amyloid (Amyloid Fibrils)IBA 09/2023 - 04/2013
5	AutoantibodiesIBA 09/2022 - 04/2013
4	perampanelIBA 12/2023 - 01/2022
4	Ion Channels (Ion Channel)IBA 12/2023 - 10/2018
3	Cyclic NucleotidesIBA 12/2023 - 11/2018
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 03/2014
3	Protein Isoforms (Isoforms)IBA 10/2018 - 07/2010
2	Glutamic Acid (Glutamate)FDA Link 02/2023 - 07/2008
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2015
2	Hyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsIBA 01/2019 - 11/2011
2	Amyloid beta-PeptidesIBA 01/2015 - 01/2015
1	Antidepressive Agents (Antidepressants)IBA 01/2024
1	Fluoxetine (Prozac)FDA LinkGeneric 01/2024
1	Lacosamide FDA Link 12/2023
1	brivaracetamIBA 12/2023
1	eslicarbazepine acetateIBA 12/2023
1	AMPA Receptors (AMPA Receptor)IBA 02/2023
1	AcidsIBA 02/2023
1	Levetiracetam (Keppra)FDA LinkGeneric 01/2023
1	Monoclonal AntibodiesIBA 09/2022
1	KCNQ2 Potassium ChannelIBA 01/2022
1	stiripentolIBA 01/2021
1	Gabapentin (Neurontin)FDA LinkGeneric 10/2020
1	PotassiumIBA 10/2020
1	Memantine (Namenda)FDA Link 10/2019
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 10/2019
1	Glucose (Dextrose)FDA LinkGeneric 06/2019
1	FilaminsIBA 01/2019
1	Caveolin 3IBA 01/2019
1	Quinidine (Chinidin)FDA LinkGeneric 10/2018
1	Phosphatidylinositols (Phosphatidylinositol)IBA 08/2018
1	IronIBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 04/2017
1	erucylphosphocholineIBA 04/2017
1	Heparin (Liquaemin)FDA LinkGeneric 01/2015
1	SteroidsIBA 01/2015
1	Neurofibromin 2 (Merlin)IBA 03/2014
1	Leucine (L-Leucine)FDA Link 07/2008
1	Leu Transfer RNAIBA 07/2008
1	Mitochondrial DNA (mtDNA)IBA 07/2008
1	Transfer RNA (tRNA)IBA 07/2008

Therapy/Procedure

4	Immunotherapy 09/2022 - 01/2015
4	Therapeutics 10/2019 - 04/2013
1	Ketogenic Diet 12/2023
1	Aftercare (After-Treatment) 11/2021